Safety study of a new peritoneal dialysis device for kidney patients
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a new device called WEAKID for people on peritoneal dialysis. It aims to see if the device is safe to use. Participants must have been on PD for at least 3 months and have no recent infections or catheter problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been on peritoneal dialysis for at least 3 months
- You have a well-working PD catheter that hasn't been replaced in the last month
- You have not had a PD-related infection (like peritonitis) in the last 8 weeks
- You have used or are using Extraneal® dialysis fluid and have no allergies to it
- You are willing to follow the study schedule and attend all visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests whether RVX000222 is safe and effective in people with end-stage kidney disease who receive hemodialysis. If you join, you’ll be carefully monitored to see how your body responds and whether it changes kidney-related health measures.
This study watches how well a certain method (percutaneous) works for placing a peritoneal dialysis (PD) catheter, which is a soft tube used for a type of kidney dialysis. By tracking patients’ experiences before and after the procedure, the study aims to improve care for people with kidney failure.
This Phase 3 trial studies how well a new peritoneal dialysis solution works and whether it is safe. It’s meant for adults with kidney failure who already do a specific type of at-home dialysis.
This study is testing a new computer tool that helps doctors see how well peritoneal dialysis (a type of kidney treatment done at home) removes waste from your body. It may help make your dialysis more effective.
This study collects information from people who use or will start using a specific type of peritoneal dialysis (PD) catheter made by Fresenius. It aims to learn more about how these catheters work in real life, which may help improve future care.
This study compares the effectiveness and resource use of remote patient monitoring across different dialysis methods for people with end-stage renal disease. It aims to see if remote monitoring can improve care and outcomes.
Hear when a new Renal Insufficiency, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.